期刊文献+

建立非均衡竞争叶酸定量测定的化学发光免疫分析法

Detection of human serum folic acid by non-equilibrium competitive immunoassay using FITC detecting system
下载PDF
导出
摘要 目的 制备抗人叶酸(FA)抗血清并应用异硫氰酸荧光素(FITC)系统开发新型非均衡竞争技术,建立可常规应用的定量检测血清 FA的化学发光免疫分析法.方法 FITC-FA类似物、FA抗体-HRP依次加入包被有抗 FITC抗体的化学发光板,形成FITC抗体-FITC-FA类似物-FA抗体-HRP的免疫反应复合物;并进行方法学评价,同时与非 FITC检测系统及罗氏化学发光免疫分析系统检测结果进行比较.结果 成功制备FA抗血清并建立基于FITC系统的非均衡竞争化学发光免疫法;经方法学评价,自研法的线性相关系数绝对值〉0.9900,灵敏度1.21 nmol/L,线性范围1.21~38.80 nmol/L,批内变异系数〈5%,自研法定量检测性能优于非FITC系统;与罗氏检测系统结果有较好相关性(R=0.9081).结论 建立的非均衡竞争定量检测血清FA化学发光免疫分析法,具有良好的检测灵敏度与特异性,可应用于常规检测. Objective To prepare anti-folic acid (FA)polyclonal antibody and develop a new non-balanced competing chemilumi-nescence analysis for clinical detection of FA.Methods Established the detection method by added FITC-FA-analogs and FA-HRP-antibody in the light emitting plate,which coated with anti-FITC antibody,to form the immune response complex of FITC/antibod-y-FITC-FA-analogs/FA-antibody-HRP.Then methodology evaluation was performed to evaluate the method performance;and fur-ther compared the detecting results with non-FITC system detection system and Electrochemiluminescence system (Roche Elecsys 2010).Results The ELISA results showed that the prepared anti-FA antibodies can recognize serum FA specificly.The methodolo-gy evaluation indicated that the linear correlation coefficient of the standard curve was 0.990 0;The analytical sensitivity was 1.21 ng/mL;the range of linear detection was 1.21—38.80 ng/mL;The coefficient variability of intra-assay was 〈5%,which was better than the results of non-FITC detection system;and the correlation coefficient was 0.998 6 compared with the Elecsys-2010 detection system.Conclusion The established chemiluminescence immunoassay for human serum FA has a good sensitivity and specificity, and suitable for clinical serum FA quantitative detecting.
出处 《检验医学与临床》 CAS 2017年第A02期44-48,共5页 Laboratory Medicine and Clinic
关键词 畀硫氰酸荧光素 非均衡竞争 叶酸 化学发光免疫分析法 folic acid FITC non-equilibrium competition chemiluminescence immunoassay
  • 相关文献

参考文献4

二级参考文献36

  • 1王健伟.河豚毒素的定量检测方法研究进展[J].国外医学(卫生学分册),1995,22(2):86-89. 被引量:14
  • 2王健伟,王德斌,罗雪云,计融,张靖,曹明华.抗河豚毒素单克隆抗体的制备及其特性的初步研究[J].卫生研究,1996,25(5):308-311. 被引量:22
  • 3Kohno K, Izumi H, Uchiumi T, et al. The pleiotropic functions of the Y-box-binding protein, YB-1. BioEssays, 2003, 25 (7) : 691-698.
  • 4Bader A G, Vogt P K. Phosphorylation by Akt disables the antioncogenic activity of YB-1. Oncogene, 2008, 27 (8) : 1179- 1182.
  • 5Bergmann S, Royer-Pokora B, Fietze E, et al. YB-I provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Res, 2005, 65(10): 4078-4087.
  • 6Chatterjee M, Rancso C, Stuhmer T, et al. The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma. Blood, 2008, 111(7) : 3714-3722.
  • 7To K, Fotovati A, Reipas K M, et al. Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. Cancer Res, 2010, 70(7) : 2840-2851.
  • 8Huang J, Tan P H, Li K B, et al. Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer. Int J Oncol, 2005, 26 (3) : 607- 613.
  • 9Szczuraszek K, Halon A, Materna V, et al. Elevated YB-1 expression is a new unfavorable prognostic factor in non-Hodgkin' s lymphomas. Anticancer Res, 2011, 31 (9) : 2963-2970.
  • 10Tay W L, Yip G W, Tan P H, et al. Y-Box-binding protein-1 is promising predictive marker of radioresistance and chemoradioresistance in nasopharyngeal cancer. Mod Pathol, 2009, 22(2) : 282-290.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部